Literature DB >> 7503936

Structure and chromosomal localization of the gene encoding the human myelin protein zero (MPZ).

K Hayasaka1, M Himoro, Y Wang, M Takata, S Minoshima, N Shimizu, M Miura, K Uyemura, G Takada.   

Abstract

We describe the cloning, characterization, and chromosomal mapping of the human myelin protein zero (MPZ) gene. The gene is about 7 kb long and consists of six exons corresponding to the functional domains. All exon-intron junction sequences conform to the GT/AG rule. The 5'-flanking region of the gene has a TA-rich element (TATA-like box), two CAAT boxes, and a single defined transcription initiation site detected by the primer extension method. The gene for human MPZ was assigned to chromosome 1q22-q23 by spot blot hybridization of flow-sorted human chromosomes and fluorescence in situ hybridization. The localization of the MPZ gene coincides with the locus for Charcot-Marie-Tooth disease type 1B, determined by linkage analysis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7503936     DOI: 10.1006/geno.1993.1400

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  9 in total

1.  Median nerve motor conduction velocity is concordant with myelin protein zero gene mutation.

Authors:  Yi-Chung Lee; Bing-Wen Soong; Yo-Tsen Liu; Kon-Ping Lin; Ker-Pei Kao; Zin-An Wu
Journal:  J Neurol       Date:  2005-02       Impact factor: 4.849

2.  Regional localization of rat myelin protein zero Mpz gene to chromosome 13q24-25 by means of FISH.

Authors:  T Liehr; A Ekici; R Hillenbrand; B Rautenstrauss
Journal:  Mamm Genome       Date:  1995-11       Impact factor: 2.957

3.  Dominant intermediate Charcot-Marie-Tooth neuropathy maps to chromosome 19p12-p13.2.

Authors:  M L Kennerson; D Zhu; R J Gardner; E Storey; J Merory; S P Robertson; G A Nicholson
Journal:  Am J Hum Genet       Date:  2001-08-28       Impact factor: 11.025

4.  Four novel mutations of the myelin protein zero gene presenting as a mild and late-onset polyneuropathy.

Authors:  Ilka Kleffner; Anja Schirmacher; Burkhard Gess; Matthias Boentert; Peter Young
Journal:  J Neurol       Date:  2010-06-18       Impact factor: 4.849

Review 5.  Intermediate Charcot-Marie-Tooth disease.

Authors:  Lei Liu; Ruxu Zhang
Journal:  Neurosci Bull       Date:  2014-10-17       Impact factor: 5.203

6.  Assignment of a second Charcot-Marie-Tooth type II locus to chromosome 3q.

Authors:  J M Kwon; J L Elliott; W C Yee; J Ivanovich; N J Scavarda; P J Moolsintong; P J Goodfellow
Journal:  Am J Hum Genet       Date:  1995-10       Impact factor: 11.025

7.  Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma.

Authors:  H Azzedine; A Bolino; T Taïeb; N Birouk; M Di Duca; A Bouhouche; S Benamou; A Mrabet; T Hammadouche; T Chkili; R Gouider; R Ravazzolo; A Brice; J Laporte; E LeGuern
Journal:  Am J Hum Genet       Date:  2003-04-08       Impact factor: 11.025

8.  Tracing myelin protein zero (P0) in vivo by construction of P0-GFP fusion proteins.

Authors:  Arif B Ekici; Sevinc Oezbey; Christina Fuchs; Eva Nelis; Christine Van Broeckhoven; Melitta Schachner; Bernd Rautenstrauss
Journal:  BMC Cell Biol       Date:  2002-11-26       Impact factor: 4.241

Review 9.  Endoplasmic Reticulum Protein Quality Control Failure in Myelin Disorders.

Authors:  Vera G Volpi; Thierry Touvier; Maurizio D'Antonio
Journal:  Front Mol Neurosci       Date:  2017-01-04       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.